Omega Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene (NCT05497453) | Omega Therapeutics | 2022-08-19 |
Track Omega Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.